# Maddalena Lettino

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/maddalena-lettino/

## Facts

| Field | Value |
| --- | --- |
| Citations | 69,221 |
| Field | Acute Myocardial Infarction Research |
| h-index | 50 |
| i10-index | 96 |
| Last Known Institution | Azienda Ospedaliera San Gerardo |
| OpenAlex ID | https://openalex.org/A5073717580 |
| ORCID iD | https://orcid.org/0000-0003-0146-9196 |
| Works | 197 |

## Researcher papers

- [2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>](https://scholariq.org/papers/2019-esc-eas-guidelines-for-the-management-of-dyslipidaemias-i-lipid/)
- [2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes](https://scholariq.org/papers/2019-esc-guidelines-for-the-diagnosis-and-management-of-chronic-coronary/)
- [2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation](https://scholariq.org/papers/2020-esc-guidelines-for-the-management-of-acute-coronary-syndromes-in-patients/)
- [2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD](https://scholariq.org/papers/2019-esc-guidelines-on-diabetes-pre-diabetes-and-cardiovascular-diseases/)
- [2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk](https://scholariq.org/papers/2019-esc-eas-guidelines-for-the-management-of-dyslipidaemias-lipid-modification/)
- [2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS](https://scholariq.org/papers/2017-esc-focused-update-on-dual-antiplatelet-therapy-in-coronary-artery-disease/)
- [2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)](https://scholariq.org/papers/2024-esc-guidelines-for-the-management-of-atrial-fibrillation-developed-in/)
- [2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes](https://scholariq.org/papers/2023-esc-guidelines-for-the-management-of-cardiovascular-disease-in-patients/)
- [European Society of Cardiology: Cardiovascular Disease Statistics 2019](https://scholariq.org/papers/european-society-of-cardiology-cardiovascular-disease-statistics-2019/)

## Researcher topics

- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)
- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)
- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)

## Researcher university

- [Azienda Ospedaliera San Gerardo](https://scholariq.org/institutions/azienda-ospedaliera-san-gerardo/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.